Chronic Myelomonocytic Leukemia Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Chronic Myelomonocytic Leukemia Market is segmented By Treatment (Chemotherapy, Hypomethylating Agents, Targeted Therapy, Stem Cell Transplantation), By Distribution Chan ....

Chronic Myelomonocytic Leukemia Market Size

Market Size in USD

CAGR6.4%

Study Period2024 - 2031
Base Year of Estimation2023
CAGR6.4%
Market ConcentrationMedium
Major PlayersImmune-Onc Therapeutics, Stemline Therapeutics, Otsuka Pharmaceutical, Novartis, Merck Sharp & Dohme
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Chronic Myelomonocytic Leukemia Market Analysis

The chronic myelomonocytic leukemia market is estimated to be valued at USD 950.2 Mn in 2024 and is expected to reach USD 1462.5 Mn by 2031, growing at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031. According to recent studies, prevalence of chronic myelomonocytic leukemia has increased by 1.5% annually over the past 5 years. Furthermore, ongoing R&D and clinical trials for novel combination therapies and targeted drugs for treatment of CML indicate promising growth opportunities for players in this market.